SEO URLwww.firestrike.ai/deals/qilu-pharmaceutical-insilico-medicine-acquisition-2026
acquisitionAnnounced · Jan 28, 2026PharmaceuticalsSource · CredibleArticle · Factual
Insilico Medicine acquires Qilu Pharmaceutical
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$120M
Target
Qilu Pharmaceutical
Madrid, Madrid
Acquirer
Insilico Medicine
Strategic Partnership
Status
Announced
Insilico Medicine agreed to acquire Qilu Pharmaceutical. Reported deal value: $120M. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Madrid, Madrid, Spain.
This page summarizes publicly available information about the transaction as of 2026-01-28. Figures and status may change as filings and press coverage update.
Copy and send link X Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical and its subsidiary Shanghai Qilu Pharmaceutical Research Center on drug development for cardiometabolic diseases
Deal timeline
Announced
Jan 28, 2026 · pharmaceutical-business-review.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $120M. Figures and status may change as sources update.
Sources: pharmaceutical-business-review.com · Primary article · FireStrike proprietary index